Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals

Documenti analoghi

• Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children
  di: Violari, Avy, et al.
  Pubblicazione: (2012)
• Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
  di: Nozza, S, et al.
  Pubblicazione: (2010)
• First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting
  di: Clumeck, Nathan, et al.
  Pubblicazione: (2014)
• Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy
  di: Banda, Clifford G., et al.
  Pubblicazione: (2018)
• Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment
  di: Shiau, Stephanie, et al.
  Pubblicazione: (2014)